HRS-AKI Treatment With TIPS in Patients With Cirrhosis

NARecruitingINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

November 29, 2022

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2026

Conditions
Cirrhosis, LiverHepatorenal SyndromeAcute Kidney InjuryAscites Hepatic
Interventions
PROCEDURE

TIPS

A transjugular intrahepatic portosystemic shunt (TIPS) is implanted into the cirrhotic liver

DRUG

Standard of Care

Terlipressin/Albumin treatment is the preferred standard of care treatment. In the case Terlipressin is not tolerated treatment with Noradrenaline may be considered following actual guidelines.

Trial Locations (14)

13353

NOT_YET_RECRUITING

Charité - Universitätsmedizin Berlin CVK, Berlin

20246

RECRUITING

University Hospital Hamburg-Eppendorf, Hamburg

30625

RECRUITING

Medical University Hannover, Hanover

45147

NOT_YET_RECRUITING

Universitätsklinikum Essen (AöR), Essen

48149

RECRUITING

University Hospital Münster, Medical Clinic B, Münster

52074

RECRUITING

University Hospital RWTH Aachen, Aachen

71640

RECRUITING

RKH Clinic Ludwigsburg, Ludwigsburg

79106

RECRUITING

University Hospital Freiburg, Freiburg im Breisgau

81377

RECRUITING

Ludwig-Maximilians-University, Klinikum Großhadern, Munich

84034

NOT_YET_RECRUITING

Klinikum Landshut AdöR der Stadt Landshut, Landshut

01307

RECRUITING

University Hospital Dresden, Medical Clinic I, Gastroenterology, Dresden

06120

RECRUITING

University Hospital Halle, Halle

07747

RECRUITING

Jena University Hospital, Clinic for Inner Medicine IV, Jena

04103

NOT_YET_RECRUITING

University Hospital Leipzig, Leipzig

Sponsors
All Listed Sponsors
collaborator

German Research Foundation

OTHER

collaborator

University Hospital Halle (Saale)

UNKNOWN

lead

Jena University Hospital

OTHER